Overview (05 Nov 2026)
Valiant Laboratories Ltd
VALIANTLAB
INE0JWS01017

Pharmaceuticals
Result was last declared on 20 May 2025
-2.41

Prev. Close
Previous Close
120.87
Current Close
118.46
Current High
118.46
Current Low
118.46
52 Week High
141.38
52 Week Low
50
Resistance 1
118.46
Resistance 2
118.46
Support 1
118.46
Support 2
118.46
Std Deviation
6.18%
DMA 200
79.81
DMA 50
120.06
DMA 20
125.90
Fundamentals and Ratios
Standalone
Trailing EPS
1.02
Forwad EPS
3.56
Trailing P/E
116.14
Forward P/E
33.28
PEG Ratio
4.49
Mkt. Cap (Cr)
Market Cap (Cr)
643.39
Total Debt(Cr)
Tot. Debt(Cr)
36.85
Reserve (Cr)
278.06
Book Value
61.89
P/BV Ratio
1.91
ROCE(%)
5.00
ROE
6.00
Consolidated
Trailing EPS
0
Forwad EPS
5.72
Trailing P/E
15.32
Forward P/E
20.71
PEG Ratio
29.13
Mkt. Cap (Cr)
Market Cap (Cr)
643.39
Total Debt(Cr)
Tot. Debt(Cr)
37.79
Reserve (Cr)
278.06
Book Value
61.21
P/BV Ratio
1.94
ROCE(%)
8.36
ROE
4.8800

 

Financial Result
Standalone
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue72.4373.4265.354.7445.99217.04
Other Income0.410.850.770.610.852.89
Total Income72.8574.2766.0855.3546.83219.94
Interest0.090.080.020.040.140.26
Expenditure-70.95-61.55-61.34-55.24-46.58-212.39
PBDT0.000.000.000.000.000.00
Depreciation-0.57-0.55-0.52-0.72-0.51-2.26
PBT1.8912.734.730.110.267.55
Tax-0.44-3.25-1.20-0.08-0.09-2.00
Equity54.3154.3154.310.000.0043.45
OPM2.5917.147.160.200.563.43
Net Profit1.459.483.530.030.175.55
NPM1.9912.765.340.060.362.52
EPS0.271.750.650.010.031.02
Consolidated
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue116.77115.2991.9852.4646.2237.468
Other Income0.110.860.170.630.872.32
Total Income116.89116.1592.1553.0947.07239.79
Interest0.961.071.010.000.141.90
Expenditure-116.22-89.95-91.11-56.08-46.79-239.02
PBDT0.000.000.000.000.000.00
Depreciation-3.66-2.86-2.930.00-0.53-6.04
PBT0.6726.191.050.000.280.77
Tax-0.26-5.090.71-4.07-0.08-4.04
Equity54.3154.3154.310.000.0054.31
OPM0.5722.551.140.000.590.32
Net Profit0.4121.11.76-7.060.2-3.27
NPM0.3518.171.91-13.290.42-1.36
EPS0.083.890.3200.040
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings